Conversation with Baxter Japan Representative Director Glen Argyle

Event Overview

What does it take to build a clinical research startup as a foreign entrepreneur in Japan’s competitive, highly regulated pharmaceutical industry? What is it like working as the first non-Japanese hire at a traditional Japanese pharmaceutical company? How do you build a clinical research operation in a company in Japan? What does the future hold for non-Japanese pharmaceutical businesses in Japan?

If you would like to know the answers to these questions and more, come join us and ask Baxter Japan Representative Director Glen Argyle yourself.

Independent Business Committee Co-Chair Steven Bleistein will begin the conversation and leave ample time for audience members to ask their own questions. No slides. No speeches. No presentations. Just fascinating and provocative conversation.

About the Speaker

Originally from New Zealand, Glen Argyle moved to Japan after graduating university and began his career as a middle school teacher in Osaka. After teaching, he joined Sumitomo Pharma (formerly Dainippon Pharmaceutical) in clinical and business development before moving into corporate strategy and portfolio management roles. He played a key role as part of the leadership team in scaling a Japanese CRO startup to 130 employees.

Argyle then moved to Takeda Yakuhin as the first foreign hire in the global corporate functions, working directly with the CEO and contributing to the globalization of the company’s operations.

He followed this by launching the CRO division at Inventiv Japan, growing it to 300 employees in three years. He then held leadership roles at Bayer Yakuhin, including head of business development and therapeutic area leads before becoming chief of staff for the Japan APAC region. He is currently president and representative director of Baxter Japan.

Co-hosts

• Australian and New Zealand Chamber of Commerce in Japan (ANZCCJ)
• CCI France Japon (CCIFJ)
• Canadian Chamber of Commerce in Japan (CCCJ)
• ACCJ Sales Development Committee
  ACCJ Healthcare Committee